Ketogenic diet for mental health: benefits, risks and evidence

What is a ketogenic diet for mental health?

A ketogenic diet restricts carbohydrate enough to increase ketone production and aims to sustain nutritional ketosis. Research protocols vary in food composition, energy intake, protein, monitoring and clinical support. Therapeutic use involves a plan for those details. ^[1][2]

A low-carbohydrate diet may improve glucose regulation without being designed to maintain ketosis. That distinction matters when reading studies that combine low-carbohydrate and very-low-carbohydrate diets. A benefit reported for a broad diet category does not establish that ketones produced the benefit.

Metabolic psychiatry considers these interventions within the wider relationship between metabolism, medication effects and mental health.

Psychiatric medication weight gain and metabolic health

Weight gain is an important concern with several psychiatric medications, particularly some antipsychotics, although risk differs substantially by drug and individual. A 2025 analysis of 30 antidepressants also found differences in physiological and cardiometabolic effects. A medication review should consider those risks alongside the medication’s psychiatric benefit. ^[4][5]

Ketogenic dietary research in serious mental illness includes a small single-arm Stanford study and a later randomized psychosis study. Both reported metabolic improvements. The controlled phase of the psychosis trial lasted one month, so longer-term effectiveness, tolerability and routine-care adherence remain important questions. ^[6][7]

Dietary treatment can be discussed alongside the existing medication plan. Relevant questions include which metabolic changes have occurred, whether the current medication remains the best clinical fit and which dietary or medical options are appropriate. Medication changes should be planned with the prescriber.

Ketogenic diets and type 2 diabetes

Low-carbohydrate dietary programs can improve glycemic control in type 2 diabetes. A 2021 review of 23 randomized trials found benefits in several six-month outcomes, with less certain medication-free remission and smaller or less certain effects at 12 months. The studies included different degrees of carbohydrate restriction and different definitions of remission. ^[8]

A small 12-month trial of 34 adults found greater HbA1c and weight reductions with a ketogenic program than with a moderate-carbohydrate comparison. Both groups received behavioral support. This provides a useful controlled finding, with uncertainty from the sample size and the full intervention delivered. ^[9]

The Keto-Med trial asked a different question. Forty participants with prediabetes or type 2 diabetes were assigned to ketogenic and Mediterranean-plus diets in random order; 33 had complete data for the primary analysis. Both diets improved HbA1c, with no between-diet difference detected after 12 weeks. The ketogenic phase lowered triglycerides more, while LDL cholesterol increased and fiber and some nutrient intakes were lower. ^[10]

These findings make diet quality, tolerability and sustained adherence part of the treatment decision. They also show why improving glucose and proving a unique benefit from ketosis are separate research questions.

Diabetes remission can occur through other structured approaches. The DiRECT trial found remission in 46% of its intensive weight-management group at one year, compared with 4% of controls. That was a supervised total-diet-replacement program in a selected population with relatively recent diabetes. ^[11]

Can a ketogenic diet help sleep apnea?

Weight management can be an important part of care for people with obesity and obstructive sleep apnea. The evidence for an additional benefit specifically from a ketogenic diet is limited.

In a 70-person randomized pilot involving patients preparing for bariatric surgery, researchers compared four weeks of CPAP alone with CPAP plus a low-calorie ketogenic diet. Apnea severity improved in both groups, with no added advantage on the apnea–hypopnea index from the diet. Some metabolic and inflammatory measures improved. ^[12]

A separate 20-person, nonrandomized study reported short-term improvements in carbon dioxide levels and sleep-breathing measures during a ketogenic intervention in obesity hypoventilation syndrome. Its population, brief exposure and sequential design limit application to routine sleep-apnea care. ^[13]

Longer-term weight-management evidence comes from other interventions. Sleep AHEAD found earlier apnea-severity benefits from intensive lifestyle treatment, while the between-group severity difference was no longer statistically significant at ten years. A different set of randomized trials found substantial apnea improvements with tirzepatide in adults with obesity. Those results concern the interventions actually tested. ^[14][15]

Dietary changes should therefore be discussed within ongoing sleep-apnea treatment. Changes to CPAP or other prescribed treatment need reassessment by the sleep clinician.

Keto for depression, bipolar disorder and psychosis

Metabolic and psychiatric outcomes may improve together, but their relationship requires careful study. A person can lose weight without the intended improvement in mood. Psychiatric symptoms may change while weight remains relatively stable.

Keto for depression

The direct depression trial aimed to limit weight change and still found substantial improvement in both diet groups. Its modest additional ketogenic effect at six weeks was sensitive to the statistical model and was not clearly sustained at 12 weeks. ^[3]

Ketogenic diets for bipolar disorder and psychosis

In the Edinburgh bipolar pilot, participants entered with relatively stable mood and 20 completed the intervention. Standard depression and mania scales did not change significantly. The study reported metabolic changes and exploratory findings, while leaving uncertainty about psychiatric efficacy. ^[16]

The 2026 psychosis trial had a one-month randomized phase. Later psychiatric improvements among 25 people in a four-month ketogenic extension were compared with their own baseline, so that phase provides a preliminary signal with greater uncertainty. ^[7]

The metabolic psychiatry evidence review compares the major studies and their limitations.

Ketogenic diet risks and medical monitoring

A clinical plan should account for current medications, medical conditions, eating history and the nutritional demands of the intervention. Monitoring should follow the actual risks and goals. Adult ketogenic-care recommendations emphasize assessment and follow-up, drawing largely on experience in neurological treatment. ^[2]

Diabetes medication

Glucose-lowering treatment may need review when carbohydrate intake changes. This is particularly relevant to insulin and sulfonylureas because of hypoglycemia risk. SGLT2 inhibitors require specific attention because ketoacidosis can occur even without markedly elevated glucose. Diabetes guidance and a serious event in the Edinburgh bipolar feasibility study make coordinated care particularly important. ^[17][18][19]

Lipids and overall cardiovascular risk

Track LDL cholesterol alongside glucose, triglycerides, blood pressure and weight. These measures can move in different directions. The LDL increase in Keto-Med makes it particularly important to assess the individual lipid response. Established cardiovascular evidence supports taking LDL-related risk seriously. ^[10][20]

Nutritional adequacy and sustainability

Food restrictions can affect fiber intake, nutrient variety, energy intake and how practical the plan is to maintain. The intervention should fit medical needs, eating history, preferences and daily life. A dietitian can help assess those questions. A plan also needs a route for reviewing adverse effects or poor adherence.

Psychiatric stability

Monitor sleep, mood, functioning and psychiatric symptoms throughout a major dietary change. A 2026 expert consensus emphasizes clinical assessment and ongoing psychiatric care, especially when symptoms are unstable. That document provides implementation opinion; efficacy still depends on the clinical trials. ^[21]

How to measure mental health and metabolic outcomes

The final distinction matters. In Look AHEAD, better weight and glycemic outcomes did not translate into a statistically significant reduction in the trial’s primary cardiovascular-event outcome. That finding concerns a specific lifestyle intervention, and illustrates the need to measure disease outcomes directly. ^[22]

Psychiatry in NYC: discussing medication and metabolic concerns

If you take psychiatric medication and are concerned about weight, blood sugar or sleep, bring those changes into the treatment discussion. Ask what has changed, what may be contributing and how psychiatric and medical care can be coordinated.

For adults who live or work in Manhattan, Integrative Psych’s NYC team can discuss clinician fit for a psychiatric evaluation or medication review at 80 Eighth Avenue in Chelsea. Confirm availability, appointment format and fees before booking. If you are considering ketogenic treatment, ask what psychiatric, medical and nutritional support would be needed for your situation.

Frequently asked questions

Can a ketogenic diet improve mental health?

Some early studies report improvement. The controlled psychiatric evidence remains limited, and the duration, diagnosis and comparison group matter. A dietary intervention should be evaluated alongside ongoing psychiatric care.

Can keto help depression?

An 88-person randomized trial found a modest additional depression benefit after six weeks. The between-group difference was not statistically significant at 12 weeks, and alternative analyses weakened the short-term finding. Longer-term effectiveness remains uncertain.

Can a ketogenic diet help bipolar disorder?

Current bipolar evidence is preliminary. In an Edinburgh pilot, participants entered with relatively stable mood, and standard depression and mania scores did not significantly change. Controlled evidence is needed to assess sustained psychiatric benefit.

Does type 2 diabetes improvement require ketosis?

Studies support several dietary approaches to improving glucose regulation. Low-carbohydrate categories include diets that do not require ketosis, and diabetes remission has also occurred in supervised weight-management programs.

Does a ketogenic diet treat obstructive sleep apnea?

Evidence for an added ketogenic effect is limited. A four-week randomized pilot found no additional apnea-severity improvement from adding a low-calorie ketogenic diet to CPAP. Continue prescribed sleep-apnea care and discuss reassessment with the sleep clinician.

Which medications need attention before carbohydrate restriction?

Glucose-lowering medications require review, especially insulin and sulfonylureas because of hypoglycemia risk and SGLT2 inhibitors because of ketoacidosis risk. Plan changes with the prescribing clinician.

Can a better glucose result still come with a higher LDL cholesterol?

Yes. These measurements can move in different directions. The Keto-Med trial found a greater triglyceride reduction and an LDL increase during its ketogenic phase. The lipid response belongs in the overall assessment.